tzi bun ng
The Chinese University of Hong Kong
Shatin, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
The Chinese University of Hong Kong
Shatin, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of California, Davis
Davis, United States
Associate Editor
Pharmacology of Ion Channels and Channelopathies
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Cambridge, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
School of Medicine, Southern Illinois University Carbondale
Springfield, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Sassari
Sassari, Italy
Associate Editor
Experimental Pharmacology and Drug Discovery
Deparment of Pharmacology, University of Granada
Granada, Spain
Associate Editor
Neuropharmacology
University of California, Davis
Davis, United States
Associate Editor
Pharmacology of Ion Channels and Channelopathies
University of Campania Luigi Vanvitelli
Caserta, Italy
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
Tokyo Medical University
Tokyo, Japan
Associate Editor
Gastrointestinal and Hepatic Pharmacology
Graduate School of Medicine, Mie University
Tsu, Japan
Associate Editor
Experimental Pharmacology and Drug Discovery
University of Milan
Milan, Italy
Associate Editor
Experimental Pharmacology and Drug Discovery
University of Florence
Florence, Italy
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
University of Florence
Florence, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
Eli Lilly (United States)
Indianapolis, United States
Associate Editor
Experimental Pharmacology and Drug Discovery
University of Brescia
Brescia, Italy
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
Pharmgenetix GmbH
Niederalm-Anif, Austria
Associate Editor
Pharmacogenetics and Pharmacogenomics